19771-63-2
中文名称
丙半胱氨酸
英文名称
Procysteine
CAS
19771-63-2
分子式
C4H5NO3S
MDL 编号
MFCD00066092
分子量
147.15
MOL 文件
19771-63-2.mol
更新日期
2025/11/06 13:24:31
19771-63-2 结构式
基本信息
中文别名
R (-)-2 -氧代噻唑啉-4-羧酸R-(-)-2-氧代噻唑啉-4-羧酸
氧代噻唑烷羧酸
L-2-氧硫杂唑烷-4-羧酸
丙半胱氨酸
英文别名
(-)-2-OXO-4-THIAZOLIDINE-CARBOXYLIC ACID2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID
(4R)-2-OXO-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID
H-L-OXOTHZ-OH
L-2-OXO-4-THIAZOLIDINECARBOXYLIC ACID
L(-)-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID
L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID
L-2-THIAZOLIDINONE-4-CARBOXYLIC ACID
L-THIAZOLIDIN-2-ONE-4-CARBOXYLIC ACID
OTC
OTZ
PROCYSTEINE
R(-)-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID
(r)-2-oxo-4-thiazolidinecarboxylicacid
(r)-4-thiazolidinecarboxylicaci
l-2-oxothiazolidine-4-carboxylate
l-4-thiazolidinecarboxylicaci
OXOTHIAZOLIDINECARBOXYLIC ACID
(-)-2-OXO-4-THIAZOLIDINECARBOXYLIC ACID CELL CULTURE
4-Thiazolidinecarboxylicacid,2-oxo-,(4R)-(9CI)
所属类别
生物化工:常见氨基酸及蛋白质类物理化学性质
熔点174 °C (dec.)(lit.)
比旋光度-60 º (c=1 in H2O)
密度1.582±0.06 g/cm3(Predicted)
折射率-64 ° (C=1, H2O)
储存条件2-8°C
溶解度DMSO(少许)、甲醇(少许)、水(少许)
酸度系数(pKa)pKa (22°): 3.32
形态粉末
颜色白色至灰白色
水溶解性溶于水
Merck13,7019
BRN4179169
InChIInChI=1S/C4H5NO3S/c6-3(7)2-1-9-4(8)5-2/h2H,1H2,(H,5,8)(H,6,7)/t2-/m0/s1
InChIKeyBMLMGCPTLHPWPY-REOHCLBHSA-N
SMILESS1C[C@@H](C(O)=O)NC1=O
安全数据
丙半胱氨酸价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/05/22 | XW021977163205 | 丙半胱氨酸 | 19771-63-2 | 100G | 822元 |
| 2025/05/22 | T1223 | L-2-噻唑烷酮-4-羧酸 L-2-Thiazolidinone-4-carboxylic Acid | 19771-63-2 | 1G | 140元 |
| 2025/05/22 | XW021977163204 | 丙半胱氨酸 | 19771-63-2 | 25G | 219元 |
常见问题列表
生物活性
Oxothiazolidinecarboxylic acid 是一种抗氧化剂,是半胱氨酸的前药,它是惰性的,在细胞内代谢成半胱氨酸,从而刺激谷胱甘肽的合成。体内研究
Oxothiazolidinecarboxylic acid treatment attenuates plantaris atrophy, restored glutathione levels, and increased catalase, Cu/Zn-SOD1, and Mn-SOD2 mRNA expression, but did not reduce other markers of oxidant stress or levels of these catabolic factors.
| Animal Model: | Male Sprague-Dawley rats (200-250 g, n= 6-7 rats/group). |
| Dosage: | 0.35% (w/v). |
| Administration: | Added to their diets at a concentration of 0.35% (w/v) for the final 12 wk. |
| Result: | Increased fiber CSAs compared to the non-supplemented, alcohol-fed group. |
